ATH 0.00% 0.4¢ alterity therapeutics limited

Ann: New commercial opportunity for PBT2, page-16

  1. 2,805 Posts.
    lightbulb Created with Sketch. 973
    I just wonder if Kempler is in the process of applying an emergence acceptance when he talks about COVID-19 :

    "Geoffrey Kempler, Alterity’s Chairman and CEO said: “Even without the effects Covid-19, antibiotic resistant pathogens kill more than 700,000 people each year and represent a major threat to global public health”.

    This time could be a possibility to get this one step forward, but a company for that is needed.
 
watchlist Created with Sketch. Add ATH (ASX) to my watchlist
(20min delay)
Last
0.4¢
Change
0.000(0.00%)
Mkt cap ! $21.28M
Open High Low Value Volume
0.4¢ 0.4¢ 0.4¢ $0 51

Buyers (Bids)

No. Vol. Price($)
102 103948983 0.4¢
 

Sellers (Offers)

Price($) Vol. No.
0.5¢ 31829254 17
View Market Depth
Last trade - 09.59am 29/07/2024 (20 minute delay) ?
ATH (ASX) Chart
arrow-down-2 Created with Sketch. arrow-down-2 Created with Sketch.